打开App
药明康德，医药CDMO龙头，价值如何？增长点在哪？
CDMO 加速增长下，医药 CXO 龙头长牛天花板打开，目前我国CDMO方向市占率极低，随着医药行业的发展，创新药成为主流，大部分医药企业会依赖CDMO服务体系，从而提高研发能力，降低研发成本。药明康德有望拉出上涨空间
价值投资股票分析63/144
App10:11
App11:00
App12:19
App09:25
App09:26
App08:06
App13:14
App14:17
App12:13
App06:19
App07:20
App08:14
App07:29
App06:31
App07:05
App09:18
App06:08
App07:45
App06:33
App08:04
App07:15
App07:08
App07:53
App04:57
App06:51
App09:20
App09:35
App10:15
App08:59
App08:31
App08:10打开App观看
